Legal experts respond to RFK Jr’s conflict-of-interest dilemma with drugmakers
In a scrutiny of Robert F. Kennedy Jr.'s pledge to transfer his economic interests in vaccine litigation, law experts criticized this movement, but Kennedy's approach is past other civil servants. Note that it is not very different from the action you took. During the hearing of Kennedy's confirmation last week, the next secretary of the […]
Drugmakers in Medicare negotiations spent more on shareholder payments and marketing than R&D last year: Report
A new report from the center-left watchdog group Accountable US found that most major drug companies spend more on marketing and shareholder payments than on research and development (R&D). of Report investigating 8 companies — Johnson & Johnson, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, and Novo Nordisk — are among the 10 drugs […]
Drugmakers give surprising response to Medicare drug price offers
Pharmaceutical executives have reacted surprisingly optimistically to Medicare’s initial offer to negotiate drug prices, signaling they are walking away from industry lawsuits warning of dire consequences for the program. While the details of the proposal remain secret and some believe the price cuts are relatively modest, patient groups say the CEO may be paying lip […]